Cytosorbents (CTSO) Non-Current Assets (2010 - 2026)

Cytosorbents' Non-Current Assets history runs 17 years deep, the most recent figure standing at $22.8 million for Q1 2026.

• Quarterly Non-Current Assets fell 10.11% year-over-year to $22.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $95.8 million (down 15.83% YoY) and the FY2025 annual result came in at $23.5 million, down 8.62% from the prior year.
• Non-Current Assets was $22.8 million for Q1 2026 at Cytosorbents, down from $23.5 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $31.5 million in Q2 2024 and bottomed at $22.8 million in Q1 2026.
• A 5-year average of $27.5 million and a median of $27.6 million in 2023 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets jumped 249.53% — and 2025, when it decreased 21.69%.
• Cytosorbents' Non-Current Assets stood at $29.5 million in 2022, then declined by 6.49% to $27.6 million in 2023, then decreased by 6.49% to $25.8 million in 2024, then declined by 8.62% to $23.5 million in 2025, then slipped by 3.16% to $22.8 million in 2026.
• Business Quant data shows CTSO's Non-Current Assets at $22.8 million in Q1 2026, $23.5 million in Q4 2025, and $24.4 million in Q3 2025.